GF-TRIPLE 20mg
€ 265
GF-TRIPLE 20 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical validation confirms purity greater than 99.8 percent with assay content 20.77 mg, retention time identification 0.98 and spectrum 992.
Endotoxin levels were below 0.001 EU per mg, with no detectable heavy metals or microbial contamination.
Supplied as a 20 mg lyophilized research peptide with full COA traceability.
Within Europe this product is supplied including bacteriostatic water; outside the EU only the peptide vial is provided.
For research use only — not for human or veterinary use.
Availability: In stock: ships within 1 day after payment confirmation.
- Multi-receptor signalling pathway modelling
- GLP-1 GIP and glucagon pathway interaction analysis
- Integrated metabolic and energy-regulation research
- Comparative structure–function investigation
- Controlled in vitro multi-axis biochemical studies
- Assay Content: 20.77 mg
- Identification – Retention Time: 0.98
- Identification – Spectrum: 992
- Purity: greater than 99.8 percent
- Endotoxins: below 0.001 EU per mg
- Microbial Growth: not detected
- Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury and vanadium
- Multi-receptor metabolic pathway analysis
- Integrated GLP-1 GIP and glucagon signalling research
- Energy regulation and biochemical modelling
- Comparative metabolic-peptide evaluation
- Controlled in vitro metabolic studies
Grail Formula Quality
Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for analytical accuracy, ultra-low endotoxin levels and reproducibility to support reliable scientific outcomes.When You Choose Grail Formula…
Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.Used solely for in vitro experiments and cannot be:
- Used in clinical trials involving humans
- Administered to humans as part of an experiment or investigation
- Supplied to another party for human investigational use
Verified and analysed with Liquilabs s.r.o. Czechia
Purity greater than 99.8 percent with validated assay content 20.77 mg
Multi-receptor metabolic research peptide
No detectable heavy metals or microbial contamination
Endotoxin level below 0.001 EU per mg
Batch GF-TRIPLE20-B241 – Published January 2026
EU shipments include bacteriostatic water
For research use only – not for human or veterinary use
For laboratory research only. Not intended for human consumption, injection, or cosmetic use.
This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.





